Inge Diepman

Today’s patient advocates meeting will be an open discussion about drug pricing. Former television presenter at the Dutch public broadcasting company, Inge Diepman will lead this relevant public discussion on drug pricing.

By creating the context and conditions similar to those faced by the CEO at a pharmaceutical company, patient advocates will experience the challenges and considerations involved in setting the price of medicines and deciding upon the direction of innovation in medicine development.

It promises as usual, to be a great, dynamic meeting where people who first hand understand the need of innovative drugs will reflect on the business side of innovation. Pharmaceutical Company Celgene, is setting the scene for the discussion and bringing inhouse experts to discuss the subject.

Important, passionate discussions are expected on today’s meeting.

Stay tuned for some reflections on the subject by well-informed patient advocates.

13 November 2018